NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
10-K - BioNexus Gene Lab Corp
Filed:
2026-04-14
AccNo:
0001477932-26-002218
Size:
8 MB
发布时间04/14 21:20 UTC
首次发现04/14 21:21 UTC
热度108.0
重要度90
情绪+0.03
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 712 字符
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]: SEC Accession No. 0001477932-26-002218
Filing Date: 2026-04-14
Accepted: 2026-04-14 17:20:27
Documents: 103
Period of Report: 2025-12-31
BioNexus Gene Lab Corp (Filer) CIK : 0001737523 (see all company filings) EIN. : 262124961 | State of Incorp.: WY | Fiscal Year End: 1231 Type: 10-K | Act: 34 | File No.: 001-41750 | Film No.: 26861734 SIC : 8071 Services-Medical Laboratories (CF Office: 08 Industrial Applications and Services)
1 | FORM 10-K | bglc_10k.htm iXBRL | 10-K
2 | CODE OF BUSINESS CONDUCT AND ETHICS | bglc_ex19.htm | EX-19
3 | LIST OF SUBSIDIARIES | bglc_ex211.htm | EX-21.1
4 | CERTIFICATION | bglc_ex311.htm | EX-31.1